| |
|
|
 |
| corporate
overview |
|
Genexion is a “full service” Clinical Research Organization that has developed a high-performance, reliable and efficient services platform to support challenging clinical development programs and trials.
Genexion's head office is located in Geneva, Switzerland, one of the largest European bioscience hubs.
Through its wholly-owned subsidiaries located in 7 key countries, Genexion offers truly global services in Europe, North America and Latin America where Genexion professionals have over 20 years of experience in conducting clinical studies and trials.
Genexion executes a large part of its operations specifically in these regions to fully capture their potential of patient pools through the exceptional performance of its investigator networks.
With its clinical research capabilities and expertise, Genexion provides a comprehensive range of strategic and operational solutions covering the whole clinical development process to assist companies in optimizing their product development programs. This is supported by a high performance proprietary product development platform specifically created by Genexion. This platform fully integrates the scientific, strategic and operational aspects of product development.
Specialized clinical research operations and dedicated teams continually support product development strategies that are required by our partners and clients. With our expertise and focus, Genexion can rapidly evolve, recommend and deploy operational and strategic plans that encompass core documents, selected staff and the appropriate selection of specialized laboratories and vendors.
|
|
|
 |
|
| corporate strategy |
|
Genexion combines the range of services of a large CRO with the clear advantages of a smaller, much personalized and accessible structure. Genexion manages projects by creating a close and focused client environment, understanding needs, exchanging ideas and blending working cultures in order to contribute rapidly and efficiently.
Using our reliable and efficient services platform, our specialized clinical research operations are specifically built on case by case basis to provide our clients and partners with tailor made solutions to support challenging clinical development programs.
We can rapidly recommend and deploy operational plans that encompass core documents, selected staff and the appropriate selection of specialized laboratories and vendors.
Key factors of the unique Genexion business model
- Strategic Regional Focus – your key to rapid patient selection
GENEXION operates in carefully selected regions with great patient recruitment potential, low operational costs, few competitive studies and high medical expertise such as Eastern Europe and Latin America. GENEXION senior management has a unique record of successfully conducting clinical operations in these regions for over two decades.
- Unparalleled Experience – your key to precise and reliable results
The exceptional record that GENEXION’s founders and Clinical Operations Department have established over many years while holding senior management positions in the pharmaceutical industry brings a unique industry experience complemented by experience acquired working with Health Authorities around the world.
-
 Talented Staff – your key to efficient project management
A pool of seasoned industry and highly skilled staff work around the clock to achieve goals and objectives beyond industry standards. In addition, GENEXION attracts and retains the best talented people in the industry by providing a unique opportunity to work in a challenging environment, on exciting research projects as well as programs which help introduce products to the market and evaluate their impact on people's lives.
Our objective is to be your partner of choice for the management of any type of clinical trial. |
|
|
|
|
|
|
|
|
|
expertise |
|
- Senior staff with an average of 20+ years experience across all fields of clinical research
|
- Protocol writing, clinical trial management, statistics, project management, data management, medical writing, event management, pharmacovigilance, DSMB, regulatory affairs
|
- Network of professionals with key industrial and governmental contacts
|
- GI, chronic inflammatory and autoimmune disease, cardiology, oncology, respiratory, cognitive, food supplements
|
- Completed over 25 international studies since 2004 (Phase I-IV)
|
|
|
|
|
|
|
